TNXP Stock: More Upside For Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP)?

In the last trading session, 2.5 million Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares changed hands as the company’s beta touched 2.22. With the company’s per share price at $0.16 changed hands at -$0.01 or -4.41% during last session, the market valuation stood at $13.73M. TNXP’s last price was a discount, traded about -2206.25% off its 52-week high of $3.69. The share price had its 52-week low at $0.16. When we look at Tonix Pharmaceuticals Holding Corp’s average trading volume, we note the 3-month average coming to 2.04 million.

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) trade information

Instantly TNXP was in red as seen at the end of in last trading. With action -6.29%, the performance over the past five days has been red. The drop to weekly highs of 0.1888 subtracted -4.41% to the stock’s daily price. The company’s shares are showing year-to-date downside of -59.68%, with the 5-day performance at -6.29% in the red. However, in the 30-day time frame, Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) is -51.10% down.

Tonix Pharmaceuticals Holding Corp (TNXP) estimates and forecasts

Data shows that the Tonix Pharmaceuticals Holding Corp share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -72.34% over the past 6 months, a 45.84% in annual growth rate that is considerably higher than the industry average of 9.40%. Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 79.31%. The 2024 estimates are for Tonix Pharmaceuticals Holding Corp earnings to decrease by -102.91%.